Headline

The latest stories from AHA Today.

The departments of Labor and the Treasury are extending certain deadlines affecting employee benefit plan participants’ rights to health coverage, portability and continuation of coverage under COBRA, and to file claims or appeal denied claims.
The Federal Reserve Board expanded eligibility for the Main Street Lending Program to businesses with up to 15,000 employees or $5 billion in annual revenue.
The Centers for Medicare & Medicaid Services announced additional regulatory waivers and rule changes to expand diagnostic testing for Medicare and Medicaid beneficiaries, telehealth in Medicare, hospital capacity and the health care workforce during the COVID-19 emergency.
The first AHA Age-Friendly Health Systems action community concluded this month, with 184 health care teams and 12 allied associations across the U.S. participating.
The Government Accountability Office recommended certain actions to enhance federal efforts to monitor and address antibiotic resistance.
Nasdaq MarketSite, the physical presence of the Nasdaq stock market in New York City’s Times Square, lit up with the 100 Million Mask Challenge.
The Alliance for Pharmacy Compounding has launched a free tool for connecting hospitals with 503B outsourcing facilities, or alternatively, 503A sterile compounding pharmacies, that can supply shortage drugs to treat COVID-19.
A new AHA resource examines the impact of the social determinants of health on patients and communities as they battle the COVID-19 outbreak.
From every corner of society, people are demonstrating a desire to help keep our health care workforce safe, write Priya Bathija, AHA vice president of strategic initiatives, and Mike Schiller, director, supply chain for The Association for Health Care Resource & Materials Management.
The Centers for Disease Control and Prevention released guidance for health care providers who care for breastfeeding women and infants who receive breast milk, based on what is currently known about the virus that causes COVID-19 and the transmission of other viral respiratory pathogens.